Conference paper Open Access

Dysregulation of mutant ALK2: More than just loss of binding of inhibitory factors

Williams, E. P.; Bullock, A. N.

Poster presented at the Biochemical Society Conference: BMP Signalling in Cancer II held at St. Annes college in Oxford, April 2019. You can read more about it here on the SGC open notebook.

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (5.3 MB)
Name Size
2019_biochemicalsociety_poster.pdf
md5:e2029f487b892d3540d153b12b9468ea
5.3 MB Download
158
43
views
downloads
All versions This version
Views 158158
Downloads 4343
Data volume 225.9 MB225.9 MB
Unique views 139139
Unique downloads 3838

Share

Cite as